Top 10 Companies in the Panobinostat Industry (2025): Market Leaders Driving Oncology Innovation
The Global Panobinostat Market was valued at USD 287.5 Million in 2023 and is projected to reach USD 472.8 Million by 2030, growing at a Compound Annual Growth Rate (CAGR) of 7.2% during the forecast period (2024–2030). This growth is fueled by increasing prevalence of multiple myeloma, rising healthcare expenditures, and expanding applications of HDAC […]